Rémy Cointreau (RMC) H1 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
H1 25/26 earnings summary
27 Nov, 2025Executive summary
Organic sales declined 4.2% year-over-year to €489.6 million in H1 2025-26, with Cognac down 7.6% and Liqueurs & Spirits up 4.1%; current operating profit (COP) fell 13.6% organically to €108.7 million, and net profit dropped 31.3% as reported to €63.1 million, with EPS at €1.22.
Americas showed strong organic sales growth (+12.8%), while APAC (-14.8%) and EMEA (-9.2%) declined; Cognac underperformed in Asia-Pacific, especially China, while Liqueurs & Spirits grew in the Americas.
The group is undergoing a strategic transformation, with a new CEO appointed in June 2025, focusing on agility, brand strategy, cost discipline, and innovation.
Five key levers for performance have been identified: organization adaptation, commercial resource rebalancing, brand DNA expression, value-driven strategy, and investment model reevaluation.
Portfolio review and innovation pipeline are prioritized, with launches targeting convenience, affordability, and cocktail culture.
Financial highlights
Gross margin decreased by 2.4 percentage points to 68.0% of sales; COP margin dropped 2.7 points to 22.2%.
Net profit group share was €63.1 million, down 31.3% as reported; EPS at €1.22, down 32.6%.
Free cash flow was negative at -€16.5 million, an improvement from -€35.6 million in H1 2024-25.
Net financial debt increased to €686.7 million, with net debt/EBITDA ratio at 2.96.
Dividend of €1.5 per share was approved, partially paid in shares.
Outlook and guidance
Full-year organic sales growth expected to be flat to low single digit; COP to decline by low double digit to mid-teens.
Tariffs and customs duties estimated to impact COP by €25 million; negative forex impact of €50–60 million on sales and €25–30 million on COP.
Sustained investments planned in China and the US to support recovery; strategic reset and midterm roadmap to be presented by November.
Latest events from Rémy Cointreau
- Q3 organic sales up 2.8% as U.S. and EMEA gains offset APAC and China weakness.RMC
Q3 2026 TU3 Feb 2026 - Q1 sales dropped 15.6% organically, with gradual recovery and cost controls underway.RMC
Q1 24/25 TU3 Feb 2026 - Sales and profit dropped, but cost savings and recovery with high single-digit growth are targeted.RMC
H2 23/241 Feb 2026 - H1 sales dropped 15.9% organically, triggering revised guidance and a major cost-cutting plan.RMC
H1 24/25 TU18 Jan 2026 - Sales and profit dropped, but margins held up due to aggressive cost controls.RMC
H1 24/2512 Jan 2026 - Q3 sales fell 21.5% organically; full-year decline near 18% with margin guidance held.RMC
Q3 24/25 TU9 Jan 2026 - Sales fell 18% organically; margin guidance held, cost savings and tariff risks remain.RMC
Q4 24/25 TU29 Nov 2025 - Sales and profit fell sharply, but cost savings and a US rebound support cautious optimism.RMC
H2 24/2521 Nov 2025 - H1 sales dropped 4.2% organically, prompting a guidance cut amid China and currency headwinds.RMC
Q2 25/26 TU31 Oct 2025